Literature DB >> 8951396

Three-dimensional covert attentional functions in Parkinson's disease subjects.

K M Bennett1, U Castiello.   

Abstract

This study assessed the ability of mildly affected Parkinson's disease (PD) subjects (n = 16) to perform attentional cognitive tasks within a three-dimensional object. A hollow cube was displayed on a computer screen and the subject was required to respond as quickly as possible to the highlighting of one of the cube angles by pressing the spacebar of the keyboard. Prior to the appearance of this imperative stimulus, the same ("valid" trials) or an alternative ("invalid" trials) angle was highlighted. For the invalid trials this meant that the subject oriented attention to the cued angle but, on imperative stimulus appearance, was unexpectedly required to redirect attention to another angle, which could be on a different cube face to that which had been cued. For one experimental session the cube was stationary, that is, object-centred and viewer-centred coordinates of a cube angle corresponded. For another session, the cube rotated such that the viewer-centred coordinates of an angle changed between appearance of the cue and appearance of the stimulus, but the angle's object-centred coordinates remained constant. The finding of lower reaction times for the valid than for the invalid trials, even when the cube was rotating, indicated that PD subjects could operate attention using an object-centred coordinate system. However, PD subjects showed exaggerated reaction times when the stimulus appeared in a cube face that was opposite to, rather than the same as, that of the invalidly cued angle. It is suggested that this reflects a dysfunction in the grouping of the structural components of the whole object at an attentional level.

Entities:  

Mesh:

Year:  1996        PMID: 8951396     DOI: 10.1007/bf00227646

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  34 in total

1.  Preserved figure-ground segregation and symmetry perception in visual neglect.

Authors:  J Driver; G C Baylis; R D Rafal
Journal:  Nature       Date:  1992-11-05       Impact factor: 49.962

2.  Spatial representation of words in the brain implied by studies of a unilateral neglect patient.

Authors:  A Caramazza; A E Hillis
Journal:  Nature       Date:  1990-07-19       Impact factor: 49.962

3.  Selective attention and the organization of visual information.

Authors:  J Duncan
Journal:  J Exp Psychol Gen       Date:  1984-12

4.  Neural integration of information specifying structure from stereopsis and motion.

Authors:  M Nawrot; R Blake
Journal:  Science       Date:  1989-05-12       Impact factor: 47.728

5.  Does visual attention select objects or locations?

Authors:  S P Vecera; M J Farah
Journal:  J Exp Psychol Gen       Date:  1994-06

6.  Object-based and environment-based inhibition of return of visual attention.

Authors:  S P Tipper; B Weaver; L M Jerreat; A L Burak
Journal:  J Exp Psychol Hum Percept Perform       Date:  1994-06       Impact factor: 3.332

7.  Cognition and the basal ganglia. Separating mental and motor components of performance in Parkinson's disease.

Authors:  R D Rafal; M I Posner; J A Walker; F J Friedrich
Journal:  Brain       Date:  1984-12       Impact factor: 13.501

8.  Principles of feature integration in visual perception.

Authors:  W Prinzmetal
Journal:  Percept Psychophys       Date:  1981-10

9.  Attention and the detection of signals.

Authors:  M I Posner; C R Snyder; B J Davidson
Journal:  J Exp Psychol       Date:  1980-06

10.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

View more
  1 in total

1.  Which figure copy test is more sensitive for cognitive impairment in Parkinson's disease: Wire cube or interlocking pentagons?

Authors:  Jane E Alty; Jeremy Cosgrove; Stuart Jamieson; Stephen L Smith; Katherine L Possin
Journal:  Clin Neurol Neurosurg       Date:  2015-10-17       Impact factor: 1.876

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.